Nexus AG
XETRA:NXU

Watchlist Manager
Nexus AG Logo
Nexus AG
XETRA:NXU
Watchlist
Price: 68.5 EUR 0.29% Market Closed
Market Cap: 1.2B EUR
Have any thoughts about
Nexus AG?
Write Note

Intrinsic Value

The intrinsic value of one NXU stock under the Base Case scenario is 59.32 EUR. Compared to the current market price of 68.5 EUR, Nexus AG is Overvalued by 13%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NXU Intrinsic Value
59.32 EUR
Overvaluation 13%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Nexus AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for NXU cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about NXU?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Nexus AG

Provide an overview of the primary business activities
of Nexus AG.

What unique competitive advantages
does Nexus AG hold over its rivals?

What risks and challenges
does Nexus AG face in the near future?

Has there been any significant insider trading activity
in Nexus AG recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nexus AG.

Provide P/S
for Nexus AG.

Provide P/E
for Nexus AG.

Provide P/OCF
for Nexus AG.

Provide P/FCFE
for Nexus AG.

Provide P/B
for Nexus AG.

Provide EV/S
for Nexus AG.

Provide EV/GP
for Nexus AG.

Provide EV/EBITDA
for Nexus AG.

Provide EV/EBIT
for Nexus AG.

Provide EV/OCF
for Nexus AG.

Provide EV/FCFF
for Nexus AG.

Provide EV/IC
for Nexus AG.

Show me price targets
for Nexus AG made by professional analysts.

What are the Revenue projections
for Nexus AG?

How accurate were the past Revenue estimates
for Nexus AG?

What are the Net Income projections
for Nexus AG?

How accurate were the past Net Income estimates
for Nexus AG?

What are the EPS projections
for Nexus AG?

How accurate were the past EPS estimates
for Nexus AG?

What are the EBIT projections
for Nexus AG?

How accurate were the past EBIT estimates
for Nexus AG?

Compare the revenue forecasts
for Nexus AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nexus AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nexus AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nexus AG compared to its peers.

Compare the P/E ratios
of Nexus AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Nexus AG with its peers.

Analyze the financial leverage
of Nexus AG compared to its main competitors.

Show all profitability ratios
for Nexus AG.

Provide ROE
for Nexus AG.

Provide ROA
for Nexus AG.

Provide ROIC
for Nexus AG.

Provide ROCE
for Nexus AG.

Provide Gross Margin
for Nexus AG.

Provide Operating Margin
for Nexus AG.

Provide Net Margin
for Nexus AG.

Provide FCF Margin
for Nexus AG.

Show all solvency ratios
for Nexus AG.

Provide D/E Ratio
for Nexus AG.

Provide D/A Ratio
for Nexus AG.

Provide Interest Coverage Ratio
for Nexus AG.

Provide Altman Z-Score Ratio
for Nexus AG.

Provide Quick Ratio
for Nexus AG.

Provide Current Ratio
for Nexus AG.

Provide Cash Ratio
for Nexus AG.

What is the historical Revenue growth
over the last 5 years for Nexus AG?

What is the historical Net Income growth
over the last 5 years for Nexus AG?

What is the current Free Cash Flow
of Nexus AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nexus AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nexus AG

Current Assets 175.5m
Cash & Short-Term Investments 112.1m
Receivables 53.3m
Other Current Assets 10.1m
Non-Current Assets 239.9m
Long-Term Investments 2m
PP&E 32m
Intangibles 200.6m
Other Non-Current Assets 5.2m
Current Liabilities 73.7m
Accounts Payable 5.8m
Accrued Liabilities 22.1m
Other Current Liabilities 45.8m
Non-Current Liabilities 75.8m
Long-Term Debt 15.3m
Other Non-Current Liabilities 60.6m
Efficiency

Earnings Waterfall
Nexus AG

Revenue
261m EUR
Cost of Revenue
-39.1m EUR
Gross Profit
221.9m EUR
Operating Expenses
-184.7m EUR
Operating Income
37.2m EUR
Other Expenses
-10.4m EUR
Net Income
26.8m EUR

Free Cash Flow Analysis
Nexus AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

NXU Profitability Score
Profitability Due Diligence

Nexus AG's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
58/100
Profitability
Score

Nexus AG's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

NXU Solvency Score
Solvency Due Diligence

Nexus AG's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Long-Term Solvency
80/100
Solvency
Score

Nexus AG's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NXU Price Targets Summary
Nexus AG

Wall Street analysts forecast NXU stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NXU is 70.97 EUR with a low forecast of 68.18 EUR and a high forecast of 73.5 EUR.

Lowest
Price Target
68.18 EUR
0% Downside
Average
Price Target
70.97 EUR
4% Upside
Highest
Price Target
73.5 EUR
7% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NXU?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NXU is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NXU Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Nexus AG Logo
Nexus AG

Country

Germany

Industry

Health Care

Market Cap

1.2B EUR

Dividend Yield

0.32%

Description

NEXUS AG engages in the development and sale of software and hardware solutions. The company is headquartered in Donaueschingen, Baden-Wuerttemberg and currently employs 1,469 full-time employees. The company went IPO on 2000-07-24. Among others, the Company provides Nexus/HIS, an information system that supports the administrative and medical/nursing areas in hospitals; Nexus/Obstetrics, a documentation software for pregnancies; is also focusing on digital pathology which controls the processes from material entry to billing; Nexus/Psychiatry, a solution for psychiatric institutions from treating patients to key figure management for institution management; CWD - Clinic WindData (E&L), a diagnostics software for the areas of endoscopy, cardiology, sonography and ophthalmology; Nexus/Home, an information system that features finance, resident and treatment management, as well as staff deployment, and Nexus/Curator, a Web-based knowledge database for quality management with document management in health care. The firm operates through subsidiaries in Austria, France, Spain, Switzerland, the Netherlands and Poland, among others.

Contact

BADEN-WUERTTEMBERG
Donaueschingen
Irmastrasse 1
+49771229600.0
www.nexus-ag.de

IPO

2000-07-24

Employees

1 469

Officers

Chairman of the Executive Board & CEO
Dr. Ingo Behrendt MBA
Chief Sales Officer & Member of the Executive Board
Mr. Ralf Heilig M.B.A.
Chief Development Officer & Member of Executive Board
Mr. Edgar Kuner
Head of Investor Relations
Ms. Melanie Ilic

See Also

Discover More
What is the Intrinsic Value of one NXU stock?

The intrinsic value of one NXU stock under the Base Case scenario is 59.32 EUR.

Is NXU stock undervalued or overvalued?

Compared to the current market price of 68.5 EUR, Nexus AG is Overvalued by 13%.

Back to Top